Also explain healing and scarring mechanism in easy language as per Robbins and Cotran pathology

Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Loading Image
Searching Images

wound healing scar formation steps granulation tissue collagen

I have all the content I need from Robbins & Cotran. Now let me compile a comprehensive, easy-to-understand explanation.

Healing and Scarring — Robbins & Cotran Pathology (Explained Simply)


The Big Picture First

When tissue is injured, the body tries to fix it in two ways:
RegenerationScar Formation
What happensNormal cells come backFibrous connective tissue fills the gap
End resultTissue looks and works like beforeTissue is structurally stable but not normal
WhenMild/superficial injurySevere injury with damage to connective tissue framework
Fig. 3.23 — Regeneration vs Scar Formation (Robbins & Cotran)
Mild injury → stem cells and progenitor cells proliferate → regeneration. Severe injury → connective tissue is deposited → scar.

Part 1: Cell Proliferation Capacity (Who Can Regenerate?)

Not all cells can regenerate equally. Robbins divides body cells into three types:

🟢 Labile (Continuously Dividing) Cells

  • Always dividing, always replacing themselves
  • Examples: skin epithelium, gut lining, bone marrow blood cells, oral/esophageal/cervical epithelia
  • These regenerate very easily after injury

🟡 Stable (Quiescent) Cells

  • Normally dormant (not dividing), but can divide when needed
  • Examples: liver cells (hepatocytes), kidney tubular cells, smooth muscle, endothelial cells, fibroblasts
  • They wake up and proliferate when injured — this is why the liver can regenerate after partial removal

🔴 Permanent (Non-Dividing) Cells

  • Lost forever once destroyed — they cannot divide
  • Examples: neurons, cardiac muscle cells (cardiomyocytes), skeletal muscle cells
  • Injury here almost always leads to scarring, not regeneration

Part 2: What Drives Regeneration? (Growth Factors & ECM)

Regeneration is driven by growth factors acting on surviving cells:
Growth FactorKey Role
EGF / TGF-αStimulate proliferation of epithelial, hepatic, and other cells
HGF (Hepatocyte Growth Factor)Promotes liver and epithelial cell growth, also called "scatter factor"
VEGFStimulates new blood vessel formation (angiogenesis)
PDGFRecruits fibroblasts and smooth muscle cells; drives scarring
FGFAngiogenesis + fibroblast activation
TGF-βThe key driver of fibrosis — stimulates collagen production
The ECM (extracellular matrix) — the scaffold of proteins and fibres surrounding cells — is equally important. It:
  • Provides a "highway" for migrating cells
  • Stores growth factors, releasing them when tissue is damaged
  • Signals cells when to stop or start dividing
Think of ECM as the building's scaffolding — without it, even cells that want to regenerate don't know where to go.

Part 3: Repair by Scarring — Steps in Scar Formation

When regeneration isn't enough (severe injury, permanent cells lost, ECM destroyed), the body fills the gap with a fibrous scar. This happens in four sequential but overlapping steps:

Step 1 — Angiogenesis (New Blood Vessels Grow In)

  • New capillaries sprout into the wound
  • Driven by VEGF and FGF
  • These vessels are leaky and bring nutrients and inflammatory cells to the repair zone

Step 2 — Migration and Proliferation of Fibroblasts

  • Fibroblasts are connective tissue cells that produce collagen
  • They are recruited from the wound margins and surrounding tissue by PDGF and FGF
  • They migrate into the wound and start multiplying
  • Macrophages are crucial here — they secrete growth factors (PDGF, TGF-β, FGF) that keep the process going

Step 3 — Granulation Tissue Formation

Granulation tissue = new capillaries + proliferating fibroblasts + macrophages + loose ECM
This is the hallmark of repair. It:
  • Appears as soft, pink, granular tissue (hence the name)
  • Fills the wound space
  • Is very vascular (bleeds easily when touched)
  • Is the "raw material" from which the scar is built
Macrophages in granulation tissue are essential — they clear debris AND secrete the signals that drive further healing.

Step 4 — Remodelling (Scar Maturation)

  • Fibroblasts lay down collagen (mainly Type III early → replaced by Type I later)
  • Blood vessels regress (the scar becomes avascular and pale)
  • Myofibroblasts (fibroblasts with contractile properties, like muscle) cause wound contraction — this physically pulls the wound edges together
  • The scar shrinks and hardens over weeks to months
  • Net result: a pale, firm, avascular scar
Think of it like wet cement drying — first soft and pliable, then it hardens and shrinks.

Part 4: Healing of Skin Wounds

Two classic patterns:

Primary Intention (Clean Surgical Wound — edges close together)

  1. Clot forms between the edges
  2. Inflammatory cells clean up debris (24–48 hrs)
  3. Epithelial cells migrate across the narrow gap within 24–48 hrs
  4. Granulation tissue forms by day 3–5
  5. Scar forms — small and neat
  6. Wound strength reaches ~70–80% of normal by 3 months

Secondary Intention (Large wound — edges far apart)

  • Much more granulation tissue needed to fill the gap
  • Wound contraction by myofibroblasts is very prominent (can reduce wound size by up to 80%)
  • Larger, more unsightly scar
  • Takes much longer to complete

Part 5: Factors That Affect Healing

Local Factors

FactorEffect
InfectionMost common cause of delayed healing — bacteria prolong inflammation and destroy tissue
Blood supplyPoor circulation → poor oxygen delivery → slow healing (e.g., diabetic foot)
Foreign bodiesSutures, fragments — keep inflammation going
Size and locationSmall, well-vascularised wounds heal better
Mechanical stressMovement at wound site disrupts healing

Systemic Factors

FactorEffect
Diabetes mellitusImpaired leukocyte function, poor vascularisation, peripheral neuropathy
Nutritional deficiencyVitamin C → collagen synthesis fails; zinc deficiency → impaired cell proliferation
Glucocorticoids (steroids)Suppress inflammation AND collagen synthesis
AgeDecreased regenerative capacity in elderly
Haematological disordersAnaemia, clotting disorders

Part 6: Abnormalities in Healing

Chronic Wounds (Defects in Healing)

Occur when the normal healing process stalls, usually due to:
  • Persistent infection
  • Ischaemia (poor blood supply)
  • Diabetes
  • Sustained pressure (pressure sores)
Healing never completes → ulcer formation.

Excessive Scarring (Too Much of a Good Thing)

TypeWhat Happens
Hypertrophic ScarExcess collagen in the wound but stays within wound boundaries; can regress over time
KeloidScar tissue grows beyond the wound margins into surrounding normal skin; more common in dark-skinned individuals; does NOT regress
ContractureExcessive wound contraction → deformity; serious problem in burns across joints
FibrosisPathological scarring of organs (lung, liver, kidney) driven by chronic inflammation and persistent TGF-β signalling

Summary Flow Chart (Simplified)

INJURY
  │
  ├─── Mild (epithelium only)
  │         └── Stem cells proliferate → REGENERATION → Normal tissue
  │
  └─── Severe (connective tissue damaged)
            └── Angiogenesis → Fibroblast recruitment
                    └── GRANULATION TISSUE forms
                            └── Collagen deposited, vessels regress, myofibroblasts contract
                                    └── MATURE SCAR (pale, firm, avascular)

Source: Robbins, Cotran & Kumar — Pathologic Basis of Disease, Chapter 3: Tissue Repair, pp. 109–120; and Robbins & Kumar Basic Pathology, corresponding section.

detailed outline on anemia, and its types. like hereditary spherocytosis, G6PD deficiency etc, for the level of MS1, w.r.t. Robbins & Cotran, Guyton & Hall

Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Searching Images

anemia classification RBC morphology peripheral smear hereditary spherocytosis sickle cell

Finding Sources
Searching Images

sickle cell anemia peripheral smear sickling hemoglobin S

Searching Images

hereditary spherocytosis peripheral smear small spherical red cells spleen

Here's your complete MS1-level anemia outline drawn directly from Robbins, Cotran & Kumar and Guyton & Hall:

Anemia — Detailed MS1 Outline

Robbins, Cotran & Kumar — Pathologic Basis of Disease | Guyton & Hall — Medical Physiology


SECTION 1: DEFINITION & OVERVIEW

Anemia = reduction of the total circulating red cell mass below normal limits → decreased oxygen-carrying capacity → tissue hypoxia.
Diagnosed clinically by:
  • ↓ Hematocrit (packed RBC volume / total blood volume)
  • ↓ Hemoglobin concentration (g/dL)
"Anemia means deficiency of hemoglobin in the blood, which can be caused by too few RBCs or too little hemoglobin in the cells." — Guyton & Hall

SECTION 2: CLASSIFICATION

2A. By Mechanism (Robbins — Table 14.1)

MechanismExamples
Blood lossAcute (trauma), Chronic (GI bleed, menorrhagia)
↑ Destruction (Hemolysis)Spherocytosis, G6PD, Sickle cell, Thalassemia, PNH, Autoimmune HA
↓ ProductionIron deficiency, Megaloblastic, Aplastic, Anemia of chronic disease

2B. By Morphology (Peripheral Smear — Clinically Useful)

MorphologyMCVCauses
Microcytic hypochromic< 80 fLIron deficiency, Thalassemia, Anemia of chronic disease
Normocytic normochromic80–100 fLAcute blood loss, Aplastic anemia, Hemolysis, CKD
Macrocytic> 100 fLMegaloblastic (B12/folate deficiency), Liver disease, Hypothyroidism

Key Red Cell Indices

IndexNormalWhat it Measures
MCV80–100 fLAverage RBC size
MCH27–33 pgHemoglobin per RBC
MCHC32–36 g/dLHemoglobin concentration in RBCs
RDW< 14.5%Variation in RBC size (↑ in iron deficiency)

SECTION 3: HEMOLYTIC ANEMIAS (Increased Destruction)

Key concept: Hemolysis = RBC destruction before normal 120-day lifespan. Can be intravascular (within blood vessels) or extravascular (in spleen/liver macrophages — most common).
Lab hallmarks of hemolysis:
  • ↓ Hb, ↓ Hematocrit
  • ↑ Reticulocytes (compensatory BM response)
  • ↑ Unconjugated (indirect) bilirubin → jaundice
  • ↑ LDH (cell lysis marker)
  • ↓ Haptoglobin (binds free Hb — gets consumed)
  • Splenomegaly (from RBC trapping)

3A. HEREDITARY SPHEROCYTOSIS (HS)

Category: Inherited red cell membrane disorder

Pathogenesis

  • Autosomal dominant (AD) in most; some AR
  • Mutations in RBC cytoskeletal proteins:
    • Ankyrin (most common), Spectrin (α or β), Band 3, Protein 4.2
  • These proteins anchor the lipid bilayer to the underlying cytoskeleton
  • Deficiency → membrane instability → RBC loses membrane fragments during repeated splenic passage (vesiculation)
  • Surface area ↓ relative to volume → sphere shape (spherocyte) instead of biconcave disc
  • Spherocytes are rigid → trapped in splenic sinusoids → destroyed by macrophages = extravascular hemolysis
"The RBCs are very small and spherical rather than biconcave discs. They cannot withstand compression forces because they do not have the normal loose, baglike membrane structure." — Guyton & Hall

Peripheral Smear

  • Small, round, dark-staining spherocytes with no central pallor
Hereditary spherocytosis — spherocytes with loss of central pallor

Diagnosis

  • Osmotic fragility test — spherocytes lyse in hypotonic saline more readily (↑ fragility)
  • EMA binding test (flow cytometry) — modern, more sensitive
  • Negative direct Coombs test (distinguishes from autoimmune HA)

Clinical Features

  • Anemia (variable severity), Jaundice, Splenomegaly
  • Pigment gallstones (excess bilirubin → calcium bilirubinate stones)
  • Aplastic crisis — triggered by Parvovirus B19 (kills erythroid precursors → sudden severe anemia)
  • Megaloblastic crisis — folate demand exceeds supply

Treatment

  • Splenectomy — removes site of destruction → cures anemia (spherocytes persist on smear, but no longer destroyed)
  • Folic acid supplementation

3B. G6PD DEFICIENCY

Category: Inherited enzyme defect (hexose monophosphate / pentose phosphate shunt)

Pathogenesis

  • X-linked recessive → mainly affects males
  • G6PD = first enzyme of the HMP shunt → generates NADPH → keeps glutathione (GSH) in reduced form
  • GSH = RBC's primary antioxidant (neutralizes H₂O₂ and superoxide)
  • Without G6PD → NADPH depleted → GSH depleted → oxidative stress unchecked
  • Oxidized hemoglobin denatures → forms Heinz bodies (precipitates on RBC membrane)
  • Macrophages "bite out" Heinz bodies → bite cells / blister cells on smear
  • Eventually → episodic hemolysis triggered by oxidative stressors

Triggers

CategoryExamples
DrugsPrimaquine, dapsone, sulfonamides, nitrofurantoin
InfectionsAny febrile illness
FoodsFava beans (favism — esp. Mediterranean variant)
MetabolicDKA (acidosis)

Key Variants

VariantPopulationSeverity
G6PD A−African AmericansMild — only old RBCs affected (young RBCs still have enzyme)
G6PD MediterraneanMediterranean, Middle EastSevere — all RBCs affected

Peripheral Smear During Crisis

  • Bite cells / blister cells
  • Heinz bodies (seen with crystal violet stain, not standard H&E)
  • Polychromasia (reticulocytosis)

Diagnosis

  • G6PD enzyme assay — best done after crisis (during crisis, deficient old cells are destroyed; only young cells with higher enzyme remain → may give false-normal result)

Clinical Features

  • Between episodes: Completely normal
  • During episode: Acute hemolytic anemia, dark urine (hemoglobinuria), jaundice, back/abdominal pain
  • Self-limiting in G6PD A− (new young RBCs replace old ones); more severe in Mediterranean variant

Treatment

  • Avoid triggers (primary prevention)
  • Supportive care during crisis; transfusion if severe

3C. SICKLE CELL DISEASE (SCD)

Category: Hemoglobinopathy (structurally abnormal globin)

Molecular Basis

  • Autosomal recessive (codominant)
  • Single point mutation in β-globin gene (chromosome 11): → Position 6: Glutamic acid → Valine → Normal HbA (α₂β₂) → HbS (α₂β^S₂)
  • HbSS = sickle cell disease (severe)
  • HbAS = sickle cell trait (asymptomatic, protective against P. falciparum malaria)

Mechanism of Sickling

  1. Deoxygenation → HbS polymerizes into long rigid tactoids (fibers)
  2. RBC distorts into a sickle/crescent shape
  3. Initially reversible (re-oxygenation un-sickles); repeated episodes → irreversibly sickled cells (permanent membrane damage)
  4. Sickled cells:
    • Are rigid → obstruct microvessels → vaso-occlusion → ischemia/infarction
    • Are fragile → destroyed by spleen → hemolysis
Factors that promote sickling: ↓ O₂ tension, dehydration, acidosis, cold, infection, high altitude
"The precipitated hemoglobin damages the cell membrane, so the cells become highly fragile, leading to serious anemia." — Guyton & Hall

Clinical Features

From Hemolysis:
  • Chronic hemolytic anemia (Hb 6–9 g/dL), jaundice, gallstones, splenomegaly (early)
  • Aplastic crisis (Parvovirus B19)
From Vaso-occlusion (Ischemia/Infarction):
OrganManifestation
Bone/marrowPainful vaso-occlusive crises (most common symptom — "bone pain")
SpleenAutosplenectomy — repeated infarcts → fibrosed shrunken spleen → ↑ risk of encapsulated bacteria
LungAcute chest syndrome — fever, chest pain, ↓ SpO₂ — leading cause of death
BrainStroke — especially in children
KidneyRenal papillary necrosis, isosthenuria (can't concentrate urine)
BonesDactylitis (hand-foot syndrome in infants), avascular necrosis of femoral head
EyesProliferative retinopathy
PenisPriapism
Skeleton"H-shaped" vertebrae on X-ray (vertebral body infarcts)

Peripheral Smear

  • Sickle cells (crescent-shaped), target cells
  • Howell-Jolly bodies (nuclear remnants — normally removed by spleen; present after autosplenectomy)
  • ↑ Reticulocytes

Diagnosis

  • Hemoglobin electrophoresis (gold standard) — HbS band present, HbA absent in HbSS
  • HPLC (newborn screening)
  • Sickling test (sodium metabisulfite)

Treatment

  • Hydroxyurea — ↑ HbF production (HbF inhibits HbS polymerization → ↓ sickling, ↓ crises)
  • Penicillin prophylaxis (for asplenic patients)
  • Vaccinations (pneumococcal, meningococcal, H. flu)
  • Folic acid supplementation
  • Exchange transfusion (acute chest syndrome, stroke)
  • Bone marrow transplantation (curative)

3D. THALASSEMIA

Category: Hemoglobinopathy — deficient globin chain synthesis
Normal Hb: α₂β₂ (HbA). Thalassemias = ↓ synthesis of one globin chain → the other accumulates → precipitates → damages RBCs.

β-Thalassemia

  • Mutations in β-globin gene (chromosome 11) — mostly point mutations (>200 known)
  • β⁰ = no β-chain produced; β⁺ = reduced β-chain produced
  • ↓ β-globin → excess α-chains accumulate → precipitate as inclusions → damage RBC membrane → ineffective erythropoiesis (death of precursors in BM) + hemolysis
  • Compensatory massive erythropoiesis → bone marrow expansion → skeletal deformities
GenotypeSyndromeSeverity
β/βNormal
β/β⁺ or β/β⁰β-Thalassemia Minor (Trait)Mild microcytosis, clinically silent
β⁺/β⁺β-Thalassemia IntermediaModerate anemia, variable transfusion need
β⁰/β⁰β-Thalassemia Major (Cooley's anemia)Severe, transfusion-dependent from 6 months
β-Thalassemia Major Clinical Features:
  • Severe hemolytic anemia appearing at 6 months (HbF → HbA switch)
  • Massive hepatosplenomegaly (extramedullary hematopoiesis)
  • "Crew-cut" skull X-ray (expanded diploe — perpendicular trabeculae)
  • Chipmunk facies (maxillary bone overgrowth)
  • Growth retardation
  • Iron overload (from transfusions + ↑ GI absorption) → hemosiderosis → heart failure, cirrhosis, endocrine failure (the main cause of death)
  • Lab: ↑ HbF, absent/↓ HbA, ↑ HbA₂
Treatment: Regular transfusions + iron chelation (deferoxamine/deferasirox); BMT (curative)

α-Thalassemia

  • Deletions in α-globin genes (chromosome 16) — normal = 4 α-genes
DeletionsSyndromeFeatures
1 gene deletedSilent carrierNormal
2 genes deletedα-Thalassemia traitMild microcytic anemia
3 genes deletedHbH diseaseModerate hemolytic anemia; excess β-chains → HbH (β₄)
4 genes deletedHydrops fetalisIncompatible with life; excess γ-chains → Hb Bart's (γ₄) — can't deliver O₂

3E. AUTOIMMUNE HEMOLYTIC ANEMIA (AIHA)

TypeAntibodyTemperatureCauses
Warm AIHAIgG37°CIdiopathic, SLE, CLL, drugs (methyldopa)
Cold AIHAIgM< 30°CMycoplasma, EBV, idiopathic
Diagnosis: Direct Coombs test (DAT) — positive Treatment: Corticosteroids (warm), cold avoidance, rituximab

3F. PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH)

  • Acquired mutation in PIG-A gene → loss of GPI-anchor proteins (CD55, CD59)
  • CD55/CD59 normally protect RBCs from complement attack
  • Without them → complement destroys RBCs → intravascular hemolysis
  • Classic triad: hemolytic anemia + thrombosis (unusual sites: hepatic vein) + cytopenias
  • Hemoglobinuria worst in morning (acidosis during sleep → complement activation)
  • Diagnosis: Flow cytometry (loss of CD55/CD59)
  • Treatment: Eculizumab (anti-C5 complement inhibitor)

SECTION 4: ANEMIAS OF DIMINISHED ERYTHROPOIESIS

4A. IRON DEFICIENCY ANEMIA — Most common anemia worldwide

Iron Metabolism

  • Absorbed in duodenum/proximal jejunum (needs acidic pH; enhanced by vitamin C; inhibited by phytates, tea)
  • Stored as ferritin (soluble) and hemosiderin (insoluble) in liver, spleen, marrow
  • Transported by transferrin in plasma

Causes

CategoryExamples
Chronic blood loss (most common in adults)GI bleeding (peptic ulcer, colorectal cancer), menorrhagia
Inadequate intakePoor diet, infancy, pregnancy
MalabsorptionCeliac disease, post-gastrectomy, achlorhydria
⚠️ "An alert clinician investigating unexplained iron deficiency anemia occasionally discovers an occult bleeding source such as cancer and thereby saves a life." — Robbins & Cotran

Lab Findings

TestIron Deficiency Anemia
Serum iron
TIBC↑ (body makes more transferrin to grab every iron molecule)
Serum ferritin↓↓↓ (earliest and most sensitive marker)
Transferrin saturation↓ (< 15%)
MCV↓ (microcytic)
MCHC↓ (hypochromic)
RDW↑ (high variation in cell size)
ReticulocytesLow (production failure)

Stages of Depletion

  1. Pre-latent: Stores depleted (↓ ferritin), normal Hb
  2. Latent: ↓ serum iron, ↑ TIBC, normal Hb
  3. IDA: Microcytic hypochromic anemia appears

Clinical Features

  • Fatigue, pallor, exertional dyspnea
  • Pica — craving for non-food items (ice, clay)
  • Koilonychia — spoon-shaped nails
  • Angular stomatitis, atrophic glossitis
  • Plummer-Vinson syndrome — IDA + esophageal webs + dysphagia (→ ↑ risk esophageal carcinoma)

Treatment

  • Find and treat underlying cause
  • Oral ferrous sulfate for 3–6 months (continue 3 months after Hb normalizes to replenish stores)
  • IV iron (malabsorption, intolerance, severe)
  • Reticulocyte response in 5–10 days = confirms diagnosis

4B. MEGALOBLASTIC ANEMIA (Vitamin B12 / Folate Deficiency)

Core Concept

Both B12 and folate needed for DNA synthesis (thymidylate production). Deficiency → cells grow but cannot divide → large immature cells = megaloblasts in BM → macrocytes in blood. All rapidly dividing cells affected (including neutrophils → hypersegmented neutrophils).
"The RBCs grow too large, with odd shapes, and are called megaloblasts... the cells are mostly oversized, have bizarre shapes, and fragile membranes." — Guyton & Hall

Vitamin B12 Deficiency

Absorption pathway: Dietary B12 (animal products) → binds Intrinsic Factor (IF) from gastric parietal cells → B12-IF complex absorbed at terminal ileum
Causes:
CauseExample
↓ IFPernicious anemia (autoimmune — anti-parietal cell Ab, anti-IF Ab), total gastrectomy
↓ Ileal absorptionCrohn's disease (terminal ileum), ileal resection, fish tapeworm (Diphyllobothrium)
↓ Dietary intakeStrict vegans (body stores last 3–5 years)
Pernicious Anemia (most important cause):
  • Autoimmune destruction of parietal cells
  • Anti-parietal cell antibodies (destroy the cells); anti-IF antibodies (block B12-IF binding)
  • Associated with Hashimoto's thyroiditis, T1DM
  • ↑ risk of gastric adenocarcinoma
Unique to B12 deficiency (not folate):
  • Subacute combined degeneration of the spinal cord — degeneration of dorsal columns (vibration/proprioception loss) + lateral corticospinal tracts (upper motor neuron signs) + peripheral neuropathy
  • Neurological damage progresses even if hematologic anemia is "corrected" by giving folate alone → dangerous

Folate Deficiency

Causes:
  • Poor diet (alcoholics, elderly, overcooking vegetables)
  • ↑ Demand (pregnancy, hemolytic anemia, rapid growth)
  • Malabsorption (celiac disease)
  • Drugs: Methotrexate, trimethoprim, phenytoin (folate antagonists)
⚠️ Folate in pregnancy: Deficiency → neural tube defects (spina bifida, anencephaly). Supplement from before conception.

Lab Findings (Both B12 and Folate)

TestFinding
MCV> 100 fL (macrocytic)
Peripheral smearHypersegmented neutrophils (≥5 lobes or ≥1 cell with 6 lobes) — pathognomonic
Bone marrowMegaloblasts, giant bands
Serum B12↓ in B12 deficiency
Serum/RBC folate↓ in folate deficiency
Homocysteine↑ in both
Methylmalonic acid (MMA)↑ in B12 only — key differentiator

Treatment

  • B12: IM cyanocobalamin (oral ineffective in pernicious anemia/malabsorption)
  • Folate: Oral folic acid
  • ⚠️ Never give folate alone if B12 deficiency suspected — corrects blood picture but neurological damage continues

4C. APLASTIC ANEMIA

Definition: Hypocellular bone marrow → pancytopenia (↓ RBCs + ↓ WBCs + ↓ platelets)

Causes

TypeMechanismExamples
Acquired (>80%)T-cell mediated autoimmune destruction of hematopoietic stem cellsIdiopathic (50%), drugs (chloramphenicol, benzene), radiation, viral (hepatitis, EBV)
InheritedGenetic defectsFanconi's anemia (AR, DNA repair defect — short stature, radial defects, ↑ risk of AML)
"Exposure to high-dose radiation or chemotherapy... damage stem cells of the bone marrow... insecticides or benzene in gasoline may cause the same effect." — Guyton & Hall

Lab Findings

  • Pancytopenia
  • Hypocellular bone marrow with fatty replacement (> 70% fat on biopsy) — diagnostic
  • ↓ Reticulocytes (production failure)
  • Normal RBC morphology

Clinical Features

  • Anemia symptoms (fatigue, pallor)
  • Infections (from neutropenia — most life-threatening)
  • Bleeding (thrombocytopenia — petechiae, ecchymoses)

Treatment

  • Severe + young with matched donor: Bone marrow transplantation (curative)
  • Severe without donor: Immunosuppression (anti-thymocyte globulin + cyclosporine + eltrombopag)
  • Supportive: transfusions, G-CSF

4D. ANEMIA OF CHRONIC DISEASE (ACD)

Most common anemia in hospitalized patients

Pathogenesis

  • Chronic infection / autoimmune disease / cancer → chronic inflammation → IL-6 → ↑ hepcidin (liver-derived)
  • Hepcidin degrades ferroportin (iron exporter on macrophages and gut enterocytes)
  • Result: iron trapped in macrophage stores, ↓ GI iron absorption → functional iron deficiency (iron present but not accessible for erythropoiesis)
  • Also: ↓ EPO response, ↓ RBC lifespan

Key Lab Comparison

TestACDIron Deficiency
Serum iron
TIBC↓ or normal
Ferritin↓↓↓
Transferrin saturation
"Storage iron in the bone marrow and serum ferritin are increased [in ACD], in contrast to iron deficiency anemia." — Robbins & Cotran

Treatment

  • Treat underlying disease
  • ESAs (erythropoietin-stimulating agents) in CKD
  • IV iron if also functionally iron-depleted

SECTION 5: PHYSIOLOGICAL EFFECTS OF ANEMIA — Guyton & Hall

Cardiovascular Compensation

  • ↓ Blood viscosity → ↓ peripheral resistance → ↑ cardiac output (↑ HR + ↑ SV)
  • Chronic severe anemia → high-output state → heart failure
  • Vasodilation from tissue hypoxia-induced local mediators

O₂ Delivery Compensation

  • 2,3-BPG (DPG) in RBCs → right-shifts O₂-Hb dissociation curve → Hb releases O₂ more easily to tissues
  • ↑ O₂ extraction fraction per unit blood

Erythropoietin Response

  • Kidney peritubular cells sense ↓ O₂ → ↑ EPO → BM → ↑ erythroid progenitor proliferation → ↑ reticulocyte release
  • Reticulocyte response begins in 3–5 days, peaks at 7–10 days

Symptoms by Severity

Hb (g/dL)Typical Symptoms
10–12Fatigue on exertion, mild pallor
7–10Exertional dyspnea, tachycardia, palpitations
< 7Rest dyspnea, angina (if CAD), heart failure, CNS symptoms
< 5Life-threatening cardiac decompensation

SECTION 6: MASTER COMPARISON TABLE

FeatureHereditary SpherocytosisG6PD DeficiencySickle Cellβ-Thal MajorIron DeficiencyB12/FolateAplastic
InheritanceADX-linked recessiveARARAcquiredAcquiredAcquired
DefectMembrane (ankyrin, spectrin)Enzyme (HMP shunt)Hb structure (Glu→Val)Hb synthesis (β↓)Iron supplyVitamin (DNA synthesis)Stem cells
MCVNormal/slight ↓NormalNormalMicrocytic ↓↓Microcytic ↓↓Macrocytic ↑↑Normal
Smear findingSpherocytesBite cells, Heinz bodiesSickle cells, targets, HJ bodiesTargets, nucleated RBCs, teardrop cellsPencil cells, microcytesHyperseg. neutrophilsNormal morphology
Hemolysis typeExtravascularIntra + extravascularBothExtravascular + ineffective erythropoiesisNoneNoneNone
SplenomegalyEarly ✓ → autosplenectomyMassive ✓
Key diagnostic testOsmotic fragility / EMA flowG6PD enzyme assayHb electrophoresisHb electrophoresisFerritin ↓↓, TIBC ↑MMA ↑ (B12), homocysteine ↑BM biopsy (hypocellular)
Key treatmentSplenectomyAvoid triggersHydroxyureaTransfusion + iron chelationOral ironIM B12 / oral folateBMT / immunosuppression

SECTION 7: MEMORY AIDS

TopicMnemonic / Trick
G6PD mechanism"No G6PD → No NADPH → No GSH → No antioxidant → Oxidative crisis → Heinz bodies → Bite cells"
IDA vs. ACDFerritin is the key: ↓ in IDA (stores empty), ↑ in ACD (stores full but locked)
B12 vs. FolateBoth: macrocytic anemia + hyperseg neutrophils. Only B12: neurological damage (subacute combined degeneration) + ↑ MMA
α-thal chromosomesAlpha = chromosome 16 (A is the 1st letter); Beta = chromosome 11 (B is 2nd letter)
Sickle cell traitHbAS = Asymptomatic + Anti-malarial (protective against P. falciparum)
Splenectomy in HSRemoves the "execution chamber" — spherocytes persist on smear but survive longer
Pernicious anemiaParietal cells make IF; if destroyed → no IF → no B12 absorption from terminal ileum
Thalassemia major skeleton"Crew-cut skull, chipmunk face, H-vertebrae" = all from marrow expansion/infarction

Sources: Robbins, Cotran & Kumar — Pathologic Basis of Disease, Ch. 14; Robbins & Kumar Basic Pathology, Ch. 13; Guyton and Hall Textbook of Medical Physiology, Ch. 33 (Red Blood Cells, Anemia, and Polycythemia).
This is a shared conversation. Sign in to Orris to start your own chat.